Global Antibody Assay Service 麻豆原创 Growth (Status and Outlook) 2025-2031

Publication ID:

LPI05252953

Publication Date:

May 9, 2025

Pages:

106

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

IT Services [2]

Software [3]

Computing & Electronics [4]

Description:

The global Antibody Assay Service market size is predicted to grow from US$ 2492 million in 2025 to US$ 4454 million in 2031; it is expected to grow at a CAGR of 10.2% from 2025 to 2031.
Antibody Assay Service is a type of medical testing service that detects the presence and quantity of specific antibodies in a person's blood. This service is often used to diagnose infections, monitor disease progression, assess the effectiveness of treatment, and evaluate the immune system's response to various antigens. The results of the assay can help doctors determine the best treatment plan for patients and assess their prognosis.
Antibody tests are typically performed using blood samples and can be either qualitative or quantitative. Qualitative tests determine if antibodies are present, while quantitative tests measure the level of antibodies in the blood. The specific type of antibody assay used will depend on the type of infection or condition being tested for, as well as the needs of the patient and their healthcare provider.
Antibody Assay Service may be offered by clinical laboratories, hospitals, or other medical facilities, and may be ordered by healthcare providers based on a patient's symptoms, medical history, and other factors. The results of the test can provide valuable information for diagnosing and treating a variety of conditions, including autoimmune diseases, infections, allergies, and other immune-related disorders.
With the continuous development of medical science, especially in the fields of immunology and oncology, there is a growing need to understand the role of antibodies in disease diagnosis, treatment, and monitoring. Antibody assay services play a crucial role in providing accurate and detailed information about antibodies, which promotes the development of related research and drives the growth of the market. The development of the biopharmaceutical industry has led to an increasing number of antibody - based drugs being developed and approved. Antibody assay services are required in the research, development, and production processes of these drugs to ensure their quality and efficacy. This has further stimulated the growth of the antibody assay service market.
North America has a well - developed medical research and biopharmaceutical industry, with abundant research funds and a high - level technical team. The United States, in particular, is a global leader in antibody assay services, with many well - known companies and research institutions. The region has a high demand for antibody assay services due to the high investment in medical research and the large number of biopharmaceutical companies.
Europe also has a strong scientific research and industrial base, especially in countries such as Germany, the United Kingdom, and France. These countries have a relatively high demand for antibody assay services, driven by the development of the biotechnology and pharmaceutical industries and the emphasis on personalized medicine. In addition, the European Union has relatively strict regulations on the quality and safety of drugs, which also promotes the development of the antibody assay service market.
The Asia - Pacific region is a rapidly growing market, driven by factors such as population growth, urbanization, and rising disposable incomes. In particular, countries like China, India, and Japan have seen significant growth in the demand for antibody assay services, due to the increasing investment in the biotechnology and pharmaceutical industries, as well as the growing awareness of personalized medicine.
The global antibody assay service market is highly competitive, with many well - known companies. The antibody assay service market has certain barriers to entry. Companies need to have professional technical teams, advanced equipment, and comply with relevant regulations and standards. In addition, establishing a good brand image and customer base requires a lot of time and resources.
The 鈥淎ntibody Assay Service Industry Forecast鈥� looks at past sales and reviews total world Antibody Assay Service sales in 2024, providing a comprehensive analysis by region and market sector of projected Antibody Assay Service sales for 2025 through 2031. With Antibody Assay Service sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Antibody Assay Service industry.
This Insight Report provides a comprehensive analysis of the global Antibody Assay Service landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Antibody Assay Service portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Antibody Assay Service market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Antibody Assay Service and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Antibody Assay Service.
This report presents a comprehensive overview, market shares, and growth opportunities of Antibody Assay Service market by product type, application, key players and key regions and countries.
Segmentation by Type:
Cells
Tissues
Serum
Segmentation by Application:
BioScience Companies
BioScience Research Institutions
Hospitals
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
JPT Peptide Technologies
Full Moon BioSystems
InSphero
Bio-Rad
ACROBiosystems
RayBiotech
Boster Bio
GenScript ProBio
OriGene
Sysmex
Capra Science

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 麻豆原创 Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 麻豆原创 Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 麻豆原创 Estimation Caveats
2 Executive Summary
2.1 World 麻豆原创 Overview
2.1.1 Global Antibody Assay Service 麻豆原创 Size (2020-2031)
2.1.2 Antibody Assay Service 麻豆原创 Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Antibody Assay Service by Country/Region (2020, 2024 & 2031)
2.2 Antibody Assay Service Segment by Type
2.2.1 Cells
2.2.2 Tissues
2.2.3 Serum
2.3 Antibody Assay Service 麻豆原创 Size by Type
2.3.1 Antibody Assay Service 麻豆原创 Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Antibody Assay Service 麻豆原创 Size 麻豆原创 Share by Type (2020-2025)
2.4 Antibody Assay Service Segment by Application
2.4.1 BioScience Companies
2.4.2 BioScience Research Institutions
2.4.3 Hospitals
2.5 Antibody Assay Service 麻豆原创 Size by Application
2.5.1 Antibody Assay Service 麻豆原创 Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Antibody Assay Service 麻豆原创 Size 麻豆原创 Share by Application (2020-2025)
3 Antibody Assay Service 麻豆原创 Size by Player
3.1 Antibody Assay Service 麻豆原创 Size 麻豆原创 Share by Player
3.1.1 Global Antibody Assay Service Revenue by Player (2020-2025)
3.1.2 Global Antibody Assay Service Revenue 麻豆原创 Share by Player (2020-2025)
3.2 Global Antibody Assay Service Key Players Head office and Products Offered
3.3 麻豆原创 Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Antibody Assay Service by Region
4.1 Antibody Assay Service 麻豆原创 Size by Region (2020-2025)
4.2 Global Antibody Assay Service Annual Revenue by Country/Region (2020-2025)
4.3 Americas Antibody Assay Service 麻豆原创 Size Growth (2020-2025)
4.4 APAC Antibody Assay Service 麻豆原创 Size Growth (2020-2025)
4.5 Europe Antibody Assay Service 麻豆原创 Size Growth (2020-2025)
4.6 Middle East & Africa Antibody Assay Service 麻豆原创 Size Growth (2020-2025)
5 Americas
5.1 Americas Antibody Assay Service 麻豆原创 Size by Country (2020-2025)
5.2 Americas Antibody Assay Service 麻豆原创 Size by Type (2020-2025)
5.3 Americas Antibody Assay Service 麻豆原创 Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Antibody Assay Service 麻豆原创 Size by Region (2020-2025)
6.2 APAC Antibody Assay Service 麻豆原创 Size by Type (2020-2025)
6.3 APAC Antibody Assay Service 麻豆原创 Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Antibody Assay Service 麻豆原创 Size by Country (2020-2025)
7.2 Europe Antibody Assay Service 麻豆原创 Size by Type (2020-2025)
7.3 Europe Antibody Assay Service 麻豆原创 Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Antibody Assay Service by Region (2020-2025)
8.2 Middle East & Africa Antibody Assay Service 麻豆原创 Size by Type (2020-2025)
8.3 Middle East & Africa Antibody Assay Service 麻豆原创 Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 麻豆原创 Drivers, Challenges and Trends
9.1 麻豆原创 Drivers & Growth Opportunities
9.2 麻豆原创 Challenges & Risks
9.3 Industry Trends
10 Global Antibody Assay Service 麻豆原创 Forecast
10.1 Global Antibody Assay Service Forecast by Region (2026-2031)
10.1.1 Global Antibody Assay Service Forecast by Region (2026-2031)
10.1.2 Americas Antibody Assay Service Forecast
10.1.3 APAC Antibody Assay Service Forecast
10.1.4 Europe Antibody Assay Service Forecast
10.1.5 Middle East & Africa Antibody Assay Service Forecast
10.2 Americas Antibody Assay Service Forecast by Country (2026-2031)
10.2.1 United States 麻豆原创 Antibody Assay Service Forecast
10.2.2 Canada 麻豆原创 Antibody Assay Service Forecast
10.2.3 Mexico 麻豆原创 Antibody Assay Service Forecast
10.2.4 Brazil 麻豆原创 Antibody Assay Service Forecast
10.3 APAC Antibody Assay Service Forecast by Region (2026-2031)
10.3.1 China Antibody Assay Service 麻豆原创 Forecast
10.3.2 Japan 麻豆原创 Antibody Assay Service Forecast
10.3.3 Korea 麻豆原创 Antibody Assay Service Forecast
10.3.4 Southeast Asia 麻豆原创 Antibody Assay Service Forecast
10.3.5 India 麻豆原创 Antibody Assay Service Forecast
10.3.6 Australia 麻豆原创 Antibody Assay Service Forecast
10.4 Europe Antibody Assay Service Forecast by Country (2026-2031)
10.4.1 Germany 麻豆原创 Antibody Assay Service Forecast
10.4.2 France 麻豆原创 Antibody Assay Service Forecast
10.4.3 UK 麻豆原创 Antibody Assay Service Forecast
10.4.4 Italy 麻豆原创 Antibody Assay Service Forecast
10.4.5 Russia 麻豆原创 Antibody Assay Service Forecast
10.5 Middle East & Africa Antibody Assay Service Forecast by Region (2026-2031)
10.5.1 Egypt 麻豆原创 Antibody Assay Service Forecast
10.5.2 South Africa 麻豆原创 Antibody Assay Service Forecast
10.5.3 Israel 麻豆原创 Antibody Assay Service Forecast
10.5.4 Turkey 麻豆原创 Antibody Assay Service Forecast
10.6 Global Antibody Assay Service Forecast by Type (2026-2031)
10.7 Global Antibody Assay Service Forecast by Application (2026-2031)
10.7.1 GCC Countries 麻豆原创 Antibody Assay Service Forecast
11 Key Players Analysis
11.1 JPT Peptide Technologies
11.1.1 JPT Peptide Technologies Company Information
11.1.2 JPT Peptide Technologies Antibody Assay Service Product Offered
11.1.3 JPT Peptide Technologies Antibody Assay Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.1.4 JPT Peptide Technologies Main Business Overview
11.1.5 JPT Peptide Technologies Latest Developments
11.2 Full Moon BioSystems
11.2.1 Full Moon BioSystems Company Information
11.2.2 Full Moon BioSystems Antibody Assay Service Product Offered
11.2.3 Full Moon BioSystems Antibody Assay Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.2.4 Full Moon BioSystems Main Business Overview
11.2.5 Full Moon BioSystems Latest Developments
11.3 InSphero
11.3.1 InSphero Company Information
11.3.2 InSphero Antibody Assay Service Product Offered
11.3.3 InSphero Antibody Assay Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.3.4 InSphero Main Business Overview
11.3.5 InSphero Latest Developments
11.4 Bio-Rad
11.4.1 Bio-Rad Company Information
11.4.2 Bio-Rad Antibody Assay Service Product Offered
11.4.3 Bio-Rad Antibody Assay Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.4.4 Bio-Rad Main Business Overview
11.4.5 Bio-Rad Latest Developments
11.5 ACROBiosystems
11.5.1 ACROBiosystems Company Information
11.5.2 ACROBiosystems Antibody Assay Service Product Offered
11.5.3 ACROBiosystems Antibody Assay Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.5.4 ACROBiosystems Main Business Overview
11.5.5 ACROBiosystems Latest Developments
11.6 RayBiotech
11.6.1 RayBiotech Company Information
11.6.2 RayBiotech Antibody Assay Service Product Offered
11.6.3 RayBiotech Antibody Assay Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.6.4 RayBiotech Main Business Overview
11.6.5 RayBiotech Latest Developments
11.7 Boster Bio
11.7.1 Boster Bio Company Information
11.7.2 Boster Bio Antibody Assay Service Product Offered
11.7.3 Boster Bio Antibody Assay Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.7.4 Boster Bio Main Business Overview
11.7.5 Boster Bio Latest Developments
11.8 GenScript ProBio
11.8.1 GenScript ProBio Company Information
11.8.2 GenScript ProBio Antibody Assay Service Product Offered
11.8.3 GenScript ProBio Antibody Assay Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.8.4 GenScript ProBio Main Business Overview
11.8.5 GenScript ProBio Latest Developments
11.9 OriGene
11.9.1 OriGene Company Information
11.9.2 OriGene Antibody Assay Service Product Offered
11.9.3 OriGene Antibody Assay Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.9.4 OriGene Main Business Overview
11.9.5 OriGene Latest Developments
11.10 Sysmex
11.10.1 Sysmex Company Information
11.10.2 Sysmex Antibody Assay Service Product Offered
11.10.3 Sysmex Antibody Assay Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.10.4 Sysmex Main Business Overview
11.10.5 Sysmex Latest Developments
11.11 Capra Science
11.11.1 Capra Science Company Information
11.11.2 Capra Science Antibody Assay Service Product Offered
11.11.3 Capra Science Antibody Assay Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.11.4 Capra Science Main Business Overview
11.11.5 Capra Science Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.